Reported Earlier, Centessa Pharmaceuticals Prices Upsized $225M Public Offering Of 15,254,237 American Depositary Shares At $14.75/ADS
Portfolio Pulse from Benzinga Newsdesk
Centessa Pharmaceuticals has announced an upsized public offering of 15,254,237 American Depositary Shares (ADS) at $14.75 per ADS, expected to raise approximately $225 million. The offering is set to close around September 16, 2024, with an option for underwriters to purchase additional shares.
September 13, 2024 | 6:32 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Centessa Pharmaceuticals has priced an upsized public offering of 15,254,237 ADS at $14.75 each, aiming to raise $225 million. The offering is expected to close on September 16, 2024, with an option for underwriters to purchase additional shares.
The public offering is significant for Centessa as it aims to raise $225 million, which could impact its stock price. However, the offering price is set, and the market may have already priced in this information, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100